Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice

Gene Therapy, Published online: 22 February 2021; doi:10.1038/s41434-021-00223-3Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice

Source: Gene Therapy - February 22, 2021 Category: Genetics & Stem Cells Authors: Tess Torregrosa Sydney Lehman Sam Hana Galina Marsh Shanqin Xu Kathryn Koszka Nicole Mastrangelo Alexander McCampbell Christopher E. Henderson Shih-Ching Lo Source Type: research